These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 34232521)
1. N-terminal domain of SARS CoV-2 spike protein mutation associated reduction in effectivity of neutralizing antibody with vaccinated individuals. Singh Y; Fuloria NK; Fuloria S; Subramaniyan V; Meenakshi DU; Chakravarthi S; Kumari U; Joshi N; Gupta G J Med Virol; 2021 Oct; 93(10):5726-5728. PubMed ID: 34232521 [No Abstract] [Full Text] [Related]
2. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7. Wang P; Nair MS; Liu L; Iketani S; Luo Y; Guo Y; Wang M; Yu J; Zhang B; Kwong PD; Graham BS; Mascola JR; Chang JY; Yin MT; Sobieszczyk M; Kyratsous CA; Shapiro L; Sheng Z; Huang Y; Ho DD Nature; 2021 May; 593(7857):130-135. PubMed ID: 33684923 [TBL] [Abstract][Full Text] [Related]
3. How 'killer' T cells could boost COVID immunity in face of new variants. Ledford H Nature; 2021 Feb; 590(7846):374-375. PubMed ID: 33580217 [No Abstract] [Full Text] [Related]
10. What the Omicron wave is revealing about human immunity. Willyard C Nature; 2022 Feb; 602(7895):22-25. PubMed ID: 35110764 [No Abstract] [Full Text] [Related]
11. Neutralising antibody escape of SARS-CoV-2 spike protein: Risk assessment for antibody-based Covid-19 therapeutics and vaccines. Focosi D; Maggi F Rev Med Virol; 2021 Nov; 31(6):e2231. PubMed ID: 33724631 [TBL] [Abstract][Full Text] [Related]
13. COVID-19: Structural Considerations for Virus Pathogenesis, Therapeutic Strategies and Vaccine Design in the Novel SARS-CoV-2 Variants Era. Volkan E Mol Biotechnol; 2021 Oct; 63(10):885-897. PubMed ID: 34145550 [TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people. Narowski TM; Raphel K; Adams LE; Huang J; Vielot NA; Jadi R; de Silva AM; Baric RS; Lafleur JE; Premkumar L Cell Rep; 2022 Feb; 38(5):110336. PubMed ID: 35090596 [TBL] [Abstract][Full Text] [Related]
15. The great escape? SARS-CoV-2 variants evading neutralizing responses. Prévost J; Finzi A Cell Host Microbe; 2021 Mar; 29(3):322-324. PubMed ID: 33705702 [TBL] [Abstract][Full Text] [Related]
16. Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain. Yang M; Li J; Huang Z; Li H; Wang Y; Wang X; Kang S; Huang X; Wu C; Liu T; Jia Z; Liang J; Yuan X; He S; Chen X; Zhou Z; Chen Q; Liu S; Li J; Zheng H; Liu X; Li K; Yao X; Lang B; Liu L; Liao HX; Chen S Microbiol Spectr; 2021 Oct; 9(2):e0135221. PubMed ID: 34643438 [TBL] [Abstract][Full Text] [Related]
17. Neutralizing Activity of BNT162b2-Elicited Serum. Liu Y; Liu J; Xia H; Zhang X; Fontes-Garfias CR; Swanson KA; Cai H; Sarkar R; Chen W; Cutler M; Cooper D; Weaver SC; Muik A; Sahin U; Jansen KU; Xie X; Dormitzer PR; Shi PY N Engl J Med; 2021 Apr; 384(15):1466-1468. PubMed ID: 33684280 [No Abstract] [Full Text] [Related]
18. A single subcutaneous or intranasal immunization with adenovirus-based SARS-CoV-2 vaccine induces robust humoral and cellular immune responses in mice. Kim E; Weisel FJ; Balmert SC; Khan MS; Huang S; Erdos G; Kenniston TW; Carey CD; Joachim SM; Conter LJ; Weisel NM; Okba NMA; Haagmans BL; Percivalle E; Cassaniti I; Baldanti F; Korkmaz E; Shlomchik MJ; Falo LD; Gambotto A Eur J Immunol; 2021 Jul; 51(7):1774-1784. PubMed ID: 33772778 [TBL] [Abstract][Full Text] [Related]
19. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Wang Z; Schmidt F; Weisblum Y; Muecksch F; Barnes CO; Finkin S; Schaefer-Babajew D; Cipolla M; Gaebler C; Lieberman JA; Oliveira TY; Yang Z; Abernathy ME; Huey-Tubman KE; Hurley A; Turroja M; West KA; Gordon K; Millard KG; Ramos V; Da Silva J; Xu J; Colbert RA; Patel R; Dizon J; Unson-O'Brien C; Shimeliovich I; Gazumyan A; Caskey M; Bjorkman PJ; Casellas R; Hatziioannou T; Bieniasz PD; Nussenzweig MC Nature; 2021 Apr; 592(7855):616-622. PubMed ID: 33567448 [TBL] [Abstract][Full Text] [Related]
20. Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine. Wu K; Werner AP; Koch M; Choi A; Narayanan E; Stewart-Jones GBE; Colpitts T; Bennett H; Boyoglu-Barnum S; Shi W; Moliva JI; Sullivan NJ; Graham BS; Carfi A; Corbett KS; Seder RA; Edwards DK N Engl J Med; 2021 Apr; 384(15):1468-1470. PubMed ID: 33730471 [No Abstract] [Full Text] [Related] [Next] [New Search]